Page last updated: 2024-08-18

arginine vasopressin and Abdominal Obesity

arginine vasopressin has been researched along with Abdominal Obesity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bankir, L; Bouby, N; Enhörning, S; Hedblad, B; Melander, O; Morgenthaler, NG; Nilsson, PM; Persson, M; Struck, J1

Other Studies

1 other study(ies) available for arginine vasopressin and Abdominal Obesity

ArticleYear
Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.
    International journal of obesity (2005), 2013, Volume: 37, Issue:4

    Topics: Age Distribution; Age of Onset; Aged; Aged, 80 and over; Albuminuria; Arginine Vasopressin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Female; Glycopeptides; Humans; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Neoplasms; Obesity, Abdominal; Predictive Value of Tests; Prevalence; Prospective Studies; Risk Factors; Sex Distribution; Sweden; Time Factors

2013